Bellicum Pharmaceuticals, Inc. Stock price OTC Markets
Equities
BLCM
US0794814048
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0748 USD | -6.68% | -6.68% | -50.17% |
Financials (USD)
Sales 2021 | 6.2M | Sales 2022 | 1.5M | Capitalization | 836K |
---|---|---|---|---|---|
Net income 2021 | -9M | Net income 2022 | -25M | EV / Sales 2021 * | - |
Net cash position 2021 * | - | Net cash position 2022 * | - | EV / Sales 2022 * | - |
P/E ratio 2021 * |
-
| P/E ratio 2022 * |
-
| Employees | 13 |
Yield 2021 * |
-
| Yield 2022 * |
-
| Free-Float | 98.45% |
1st Jan change | Capi. | |
---|---|---|
+2.56% | 108B | |
+10.02% | 104B | |
+6.70% | 23.66B | |
-11.91% | 22.1B | |
-3.29% | 19.71B | |
-35.98% | 18.2B | |
-14.02% | 16.19B | |
+4.61% | 13.72B | |
+35.05% | 12.22B |
- Stock
- Equities
- Stock Bellicum Pharmaceuticals, Inc.
- Stock Bellicum Pharmaceuticals, Inc. - OTC Markets